Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 3,200.00
+20.00 (0.63%)
At close: Jan 26, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 402.57 billion as of January 30, 2026. Its market cap has increased by 336.46% in one year.
Market Cap
402.57B
Enterprise Value
443.21B
Revenue
29.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,200.00
Market Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 402.57B, an increase of 434.51%. That is a compound annual growth rate of 17.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 402.57B | 160.49% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 474.83B |
| Cytogen | 179.94B |
| GENINUS | 136.41B |
| HLB PANAGENE Co., LTD. | 85.30B |
| Green Cross Medical Science | 84.68B |
| Protia | 72.11B |
| Seoulin Bioscience | 59.58B |
| GeneMatrix | 49.45B |